title: The Kyoto Prognostic Index for patients with diffuse large B-cell lymphoma in the rituximab era.
authors.affiliation: Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Kobayashi
authors.affiliation: Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
authors.forename: J
authors.initials: J
authors.lastname: Kuroda
authors.affiliation: Department of Biostatistics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
authors.forename: I
authors.initials: I
authors.lastname: Yokota
authors.affiliation: Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.|Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Tanba
authors.affiliation: Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Fujino
authors.affiliation: Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Kuwahara
authors.affiliation: Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
authors.forename: R
authors.initials: R
authors.lastname: Isa
authors.affiliation: Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
authors.forename: J
authors.initials: J
authors.lastname: Yamaguchi
authors.affiliation: Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
authors.forename: E
authors.initials: E
authors.lastname: Kawata
authors.affiliation: Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Akaogi
authors.affiliation: Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.|Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Uchiyama
authors.affiliation: Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.|Department of Hematology, Aiseikai Yamashina Hospital, Kyoto, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Kaneko
authors.affiliation: Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
authors.forename: N
authors.initials: N
authors.lastname: Uoshima
authors.affiliation: Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Kobayashi
authors.affiliation: Department of Biostatistics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Teramukai
authors.affiliation: Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Taniwaki
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy* / Q000401:mortality*; D011379:Prognosis; D000069283:Rituximab / Q000008:administration & dosage
chemical_list: D000069283:Rituximab